Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study - Wikidata - wikimedia - TriplyDB

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study

http://www.wikidata.org/entity/Q33735469

about

Recent progress in pancreatic cancer Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?Neoadjuvant radiotherapeutic strategies in pancreatic cancer Adjuvant therapy for pancreas cancer in an era of value based cancer care Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions Clinical Management of Pancreatic Cancer A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.Therapeutic options for the management of pancreatic cancer.Applying next-generation sequencing to pancreatic cancer treatment.Adjuvant chemoradiotherapy for resected pancreas cancer 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.Molecular characteristics of pancreatic ductal adenocarcinoma Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new.Radiotherapy and erlotinib combined: review of the preclinical and clinical evidence Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer Analysis of local control in patients receiving IMRT for resected pancreatic cancers Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma.Meta-analyses of treatment standards for pancreatic cancer.The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer Aggressive secondary surgery for local recurrence of pancreatic cancer.Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma Integrative survival-based molecular profiling of human pancreatic cancer.Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.

P2860

Q24626346-4F406B21-F024-4CD6-965F-796B7E7AF2A2 Q26746031-34AB6296-37C5-4B92-8900-E46B26E0C2B3 Q26766686-922A1356-EBE9-49BD-9721-C184A6846241 Q26775916-D00CFAB8-D0F3-4AE4-9AD9-7CA8C8B6CA57 Q26796495-365A31D8-B600-4855-9AB1-7E52C4E0CF77 Q28072182-77DAF26F-EC76-4A8F-95DE-64604C5FA983 Q28084173-4E481513-F287-477C-BD10-B4678DF64CE6 Q30238706-4890411B-0724-45AB-974F-E4D5C49CDB06 Q30987695-9324A49B-626C-4745-972F-2AD8A15B4E0F Q33631833-56458065-D77E-4DE2-9022-97779C08D249 Q33733149-701B0767-BBBA-4FC6-8EA3-B22C1B91EA8D Q33820788-B359A0B6-BAFE-4B04-8300-1ADC206641C3 Q34048461-9C659C5A-AE61-4187-8597-2A597710B94C Q34093776-5442EC3A-A644-4150-9A50-D4F3C5A1B8C4 Q34285351-4351ECE2-2E0D-440D-9516-BF614DDE631B Q34398248-53DC539C-9F3D-4E01-8275-664300BCAF0C Q34636501-2BBF8694-DA04-431F-B671-F06F0EC3393F Q34745252-5B7593E2-1F23-4A6A-A7B7-BD8E4DC97EC0 Q34774546-798D32FF-1E1E-492D-BCBD-FD81074BDDDC Q35076334-931DD318-7C82-492D-B876-5396E8D92A1B Q35430053-86375589-062B-49E1-BAB1-BB983538B367 Q35504794-D07A9222-82B0-4C8D-B564-1A3B5AF7A64C Q35679643-E37C6272-1636-4549-83A3-49C7F0AF8449 Q35787410-F61F6E87-A451-4414-9789-ECD6BED3D05C Q35851281-FE5902B5-8A0A-45B5-8779-CA8A966A0980 Q35970960-DC5C4B3C-B4CA-450E-91C1-0E7DB1356373 Q36011003-3A82104A-7330-44B7-B6F3-9EC3CDF07498 Q36029954-1ABDD9B3-E2CA-4358-B07C-4B58DA16B800 Q36058855-DAB3667B-0E53-4384-9AC9-14FBF0BBA209 Q36567665-75D455C4-F69F-4919-BE21-F3A868CBFF07 Q36626643-8AD61F79-31B4-4EFE-B842-AA457DDCF626 Q36637079-25EB3621-F086-4DED-9162-4523E32656BF Q36640493-54A91388-6B83-4E9F-A41D-4E39C343C10B Q36773130-792D51F6-13E4-4010-A024-3BEE93D539D4 Q36987227-2A2FBB39-ED3D-4C16-9BBF-D5A554975348 Q37191059-5CAC6137-4260-4F4C-B048-6EA850F69CD6 Q37276948-B2561AEA-609A-4DAF-A008-DAD101CD86D1 Q37294997-8F87E2E6-EEEE-4149-8708-9B283799F23A Q37403232-4AA3BC28-9B47-477C-BE3C-4C4628620EC3 Q37522823-0171B5F4-C2E9-42D8-A877-4DB7ACFA7F8E

P2860

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study

http://www.wikidata.org/entity/Q33735469

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@ast

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@en

type

label

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@ast

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@en

prefLabel

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@ast

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@en

P1433

Q33735469-AD630605-9D6D-48A0-B8DE-3E8C15C15E14

P1476

Q33735469-D365C633-C9D7-41EA-BB25-6BB1CC676967

P2093

Q33735469-2D4CC41B-E639-44CC-B51B-88A0B3371AE8

Q33735469-52013608-6375-427A-8485-D1E19EE60564

Q33735469-53949881-823C-4983-9DA2-34A064506070

Q33735469-738D778A-D3F4-44A9-91CB-8466EDC240D7

Q33735469-82FCBC55-2906-47EF-9D8B-F0BB99636B56

Q33735469-B58C1C80-5A69-4F10-A0A3-FFF0D7B76D07

Q33735469-B8881F64-0F50-4F8E-8757-4EC5931BD640

Q33735469-BCA96313-B464-4A66-9F6E-CA44B4036E62

Q33735469-CC298F91-44A0-4413-A88B-9DB804F13DA7

Q33735469-D46F9FD5-1E49-4473-8415-E171AAB2482C

P2860

Q33735469-26160616-55DB-4544-8AD0-E437A0B80286

Q33735469-34D1601C-72BD-4FFB-99E2-6F2CB987997D

Q33735469-374E0CBC-19FB-4076-BC51-CE826BBA78F3

Q33735469-49969B8D-B199-442A-A697-6E96CEADC88F

Q33735469-50A5B131-A61F-4B73-883C-399513033B90

Q33735469-63EF25BA-90FD-49F8-A532-B07432372C91

Q33735469-73328037-ABA1-4888-A7A7-5572C8E509E9

Q33735469-73E5579B-D257-47A5-A738-734C4D15721E

Q33735469-743A6FA0-9642-4B5B-BEE4-E05B306876B1

Q33735469-840417AD-6AB3-4FE4-BF0C-E45DD2B466B0

P2888

Q33735469-C3C80752-C7A9-4E40-B0FC-9F25BA5D9CFB

P304

Q33735469-92C5D8A9-8916-4888-924C-5147A86E953F

P31

Q33735469-DCF278CC-4549-493F-9C8F-054629BD51F9

P356

Q33735469-1255B200-3E03-4A11-B47B-C02D8DA38CC7

P433

Q33735469-9AB3A236-3D04-4BB3-A319-6B79BE7739E2

P478

Q33735469-5288CFB7-91F6-4EED-A2AE-C3727110865A

P50

Q33735469-816D61C9-6C28-410F-9A43-8E73DCA32166

P577

Q33735469-AEC5000B-E3CA-43D5-8BDF-41680A59BEBA

P5875

Q33735469-82F8D495-E7CB-495E-8FE0-72EB0E50084A

P6179

Q33735469-2ADA03EA-06E7-4D72-8A15-999234A84866

P698

Q33735469-5E28F1C6-1685-41AA-9BB7-337A2C7E3203

P921

Q33735469-37F33F70-A11B-4FC5-B340-77DF9BCF1991

Q33735469-57A36CB1-5241-4C8E-9155-537FD6DB7A32

Q33735469-802DECD0-6D13-4BDE-ABE8-3595FE7BF38D

P932

Q33735469-4623A4C2-EB29-4D48-9AFE-27567D2826D2

P356

S10434-009-0743-7

P1433

Annals of Surgical Oncology

P1476

Adjuvant chemoradiation for pa ...... ayo Clinic collaborative study

@en

P2093

Charles C Hsu

http://www.w3.org/2001/XMLSchema#string

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

Daniel A Laheru

http://www.w3.org/2001/XMLSchema#string

John L Cameron

http://www.w3.org/2001/XMLSchema#string

Jordan M Winter

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

Leonard L Gunderson

http://www.w3.org/2001/XMLSchema#string

Matthew D Callister

http://www.w3.org/2001/XMLSchema#string

Michael B Farnell

http://www.w3.org/2001/XMLSchema#string

Michael G Haddock

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Cancer statistics, 2009

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

One thousand consecutive pancreaticoduodenectomies.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

The case for adjuvant chemoradiation for pancreatic cancer.

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

P2888

s10434-009-0743-7

P304

981-990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-009-0743-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41089860

http://www.w3.org/2001/XMLSchema#string

P6179

1045108945

http://www.w3.org/2001/XMLSchema#string

P698

20087786

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2840672

http://www.w3.org/2001/XMLSchema#string